We Help Companies Find New Sales Opportunities
BTG is to acquire Biocompatibles, the Farnham-based supplier of drug devices, for £156m.
BTG has sold VisionTec, the contact lens technology company, to 1-800 Contacts of the US, and the business will be renamed Clearlab UK.
BTG, the intellectual property manager, is planning to raise £121m in a rights issues, in order to set up a separate biotechnology group, expand into North America and fund joint ventures with other technology companies.
BTG, the intellectual property manager, is planning to invest £25m over the next five years on clinical trials for its Varisolve treatment for varicose veins.